Back
Novo Nordisk A/S Stock Price Chart
Sponsored
NONOF
Sponsored
Will Crypto Make People Rich Again Starting April 2024?
Details on how to profit here.
Buy
67
NONOF
Novo Nordisk A/S
Last Price:
121.51
Seasonality Move:
3.92%
7 Day Trial
ALL ACCESS PASS
$
7
The little-known AI stock you need to read about now...
Get the name - FREE.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing selling pressure, which indicates risk of future bearish movement.
Novo Nordisk A/S Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 125.3 | Sell |
20-day SMA: | 124.81 | Sell |
50-day SMA: | 126.76 | Sell |
200-day SMA: | 105.98 | Buy |
8-day EMA: | 124.82 | Sell |
20-day EMA: | 125.29 | Sell |
50-day EMA: | 124.08 | Sell |
200-day EMA: | 108.05 | Buy |
Novo Nordisk A/S Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.34 | Sell |
Relative Strength Index (14 RSI): | 42.47 | Sell |
Chaikin Money Flow: | -7508 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (123.07 - 127.13) | Sell |
Bollinger Bands (100): | (106.79 - 128.81) | Buy |
Novo Nordisk A/S Technical Analysis
Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Novo Nordisk A/S Stock
Is Novo Nordisk A/S Stock a Buy?
- Novo Nordisk A/S share price is 121.51 while NONOF 8-day simple moving average is 125.30, which is a Sell signal.
- The stock price of NONOF is 121.51 while Novo Nordisk A/S 20-day SMA is 124.81, which makes it a Sell.
- Novo Nordisk A/S 50-day simple moving average is 126.76 while NONOF share price is 121.51, making it a Sell technically.
- NONOF stock price is 121.51 and Novo Nordisk A/S 200-day simple moving average is 105.98, creating a Buy signal.
NONOF Technical Analysis vs Fundamental Analysis
Buy
67
Novo Nordisk A/S (NONOF)
is a Buy
Is Novo Nordisk A/S a Buy or a Sell?
-
Novo Nordisk A/S stock is rated a Buy
The current Novo Nordisk A/S [NONOF] share price is $121.51. The Score for NONOF is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
Novo Nordisk A/S Stock Info
Market Cap:
543.62B
Price in USD:
121.51
Share Volume:
11.65K
Novo Nordisk A/S 52-Week Range
52-Week High:
140.32
52-Week Low:
74.70
Buy
67
Novo Nordisk A/S (NONOF)
is a Buy
Novo Nordisk A/S Share Price Forecast
-
What is the Novo Nordisk A/S stock price today?
The Novo Nordisk A/S stock price is 121.51 USD today. -
Will NONOF stock go up or go down?
Novo Nordisk A/S> share price is forecast to RISE/FALL based on technical indicators -
Is Novo Nordisk A/S overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Novo Nordisk A/S is not overvalued.
Is Novo Nordisk A/S Stock a Buy?
- Novo Nordisk A/S share price is 121.51 while NONOF 8-day exponential moving average is 124.82, which is a Sell signal.
- The stock price of NONOF is 121.51 while Novo Nordisk A/S 20-day EMA is 125.29, which makes it a Sell.
- Novo Nordisk A/S 50-day exponential moving average is 124.08 while NONOF share price is 121.51, making it a Sell technically.
- NONOF stock price is 121.51 and Novo Nordisk A/S 200-day simple moving average is 108.05, creating a Buy signal.
Fundamental Analysis of Novo Nordisk A/S
Is Novo Nordisk A/S a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.
Technical Analysis of Novo Nordisk A/S
Should I short Novo Nordisk A/S stock?
- NONOF Moving Average Covergence Divergence (MACD) indicator is -0.34, suggesting Novo Nordisk A/S is a Sell
- Novo Nordisk A/S Relative Strength Index (RSI) is 42.47, which suggest Novo Nordisk A/S is oversold
- The Bollinger Bands (25) for Novo Nordisk A/S is (123.07 - 127.13), which suggest Novo Nordisk A/S is a Buy
- The Bollinger Bands (100) for Novo Nordisk A/S is (106.79 - 128.81), which suggest Novo Nordisk A/S is a Buy
* Novo Nordisk A/S stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.